Many transport proteins, including pumps, channels, and transporters, are regulated by phosphoinositides. This rapidly expanding list includes voltage-gated K ϩ channels, inwardly rectifying K ϩ channels, and members of the TRP channel family, ENaC, NHE1, and NBCe1 (1-8). This regulation has been explained on the basis of two contrasting mechanisms. (i) There is direct phosphoinositide interaction with specific amino acids in the transport protein, explained either on the basis of charge (8 -13) or presence of canonical lipid binding domains such as pleckstrin homology domains (1,8,14). Common to these direct interaction studies has been the demonstration that mutagenesis of specific amino acids leads to changes in molecular interactions with phosphoinositides that lead to subsequent changes in physiologic channel or transporter activity.(ii) An indirect mechanism involves an additional intermediate, either protein or lipids, that binds via a phosphoinositide-dependent mechanism (5, 11).Sodium/hydrogen exchangers (SLC9a family) are ubiquitous transporters serving many functions in the cell, including regulation of intracellular pH, cell volume, and sodium absorption (15, 16). Grinstein and co-workers (17) have demonstrated that NHE1, the ubiquitous member of the sodium hydrogen exchanger gene family, is regulated by PI(4,5)P 2 , which binds to its C terminus. Using a unique whole cell patch pipette technique, Fuster et al. (18) showed that NHE3 is rapidly stimulated in opossum kidney cells by intracellular application of PI(3,4,5)P 3 .2 However, the mechanism of this stimulation is unknown. We hypothesized that the epithelial brush border Na ϩ /H ϩ antiporter NHE3 binds phosphoinositides based on the recognition that gene families have similar structural/functional organization (19). The aim of this study was to understand the mechanism of NHE3 regulation by phosphoinositides by the following: (i) investigating whether NHE3 can directly bind phosphoinositides; (ii) identifying regions and amino acids that are necessary for this interaction, and (iii) studying the physiologic relevance of this interaction.
EXPERIMENTAL PROCEDURESMaterials-Lipids, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, PI(3,4,5)P 3 , and PI(4,5)P 2 were from Avanti Polar Lipids. QuikChange site-directed mutagenesis kit was from Stratagene (La Jolla, CA). EZ-link sulfo-NHS-*